Canada’s regulatory approach to drugs for rare diseases: orphan drugs

Description

Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.

Resources

Name Format Description Link
Canada’s regulatory approach to drugs for rare diseases: orphan drugs HTML Open resource
Canada’s regulatory approach to drugs for rare diseases: orphan drugs HTML Open resource

Tags

Topics

Categories